Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta‐analysis of randomized clinical trials
International Journal of Dermatology · 2025-03 · 64 (3) · 479-484
DOI: 10.1111/ijd.17524 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Dermatology, online erschienen am 19.10.2024. Verfasst von Milene Vitória Sampaio Sobral und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Western Sao Paulo, Presidente Prudente, Brazil. Hauptthemen laut MEDLINE: Minoxidil, Alopecia, Vasodilator Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
The benefits and potential risks of oral minoxidil therapy versus topical minoxidil therapy in patients with androgenetic alopecia (AGA) are controversial. We systematically searched PubMed, Embase, and Cochrane for randomized clinical trials (RCTs) comparing the use of oral minoxidil and minoxidil topical solution in patients with AGA. Statistical analyses were performed using R Studio 4.3.2. Standard mean difference (SMD) and risk ratio (RR) with 95% confidence intervals (CI) were pooled across trials. This meta‐analysis included four RCTs reporting data on 279 patients. Follow‐up ranged from 24 to 39 weeks. There were no differences in hair density (SMD 0.02; 95% CI −0.25 to 0.29; P = 0.88; I 2 = 0%) or hair diameter (SMD −0.25; 95% CI −0.75 to 0.26; P = 0.34; I 2 = 36%). The incidence of hypertrichosis was statistically significantly higher in the oral minoxidil group when compared to the topical minoxidil group (RR 2.01; 95% CI 1.18–3.41; P = 0.01; I 2 = 0%). There was no statistically significant difference between groups for the incidence of hypotension (RR 2.42; 95% CI 0.26–22.46; P = 0.44; I 2 = 0%). In patients with AGA, oral minoxidil and minoxidil topical solution have similar efficacy and safety, with equivalent improvements in hair density, hair diameter, and incidence of adverse events, such as hypotension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Western Sao Paulo, Presidente Prudente, Brazil.
- State University of Feira de Santana, Feira de Santana, Brazil.
- Federal University of Minas Gerais, Belo Horizonte, Brazil.
- University of Miami, Miami, FL, USA.
- Federal University of the Jequitinhonha and Mucuri Valleys, Diamantina, Brazil.
- Franciscana University, Santa Maria, Brazil.
ORCID-Profile: Milene Vitória Sampaio Sobral, Livia Kneipp Rodrigues, Rafaela da Cunha Pirolla
Zitieren
APA
Sobral, M. V. S., Moreira, J. L. M. L., Rodrigues, L. K., Rocha, P., Pirolla, R. D. C., Soares, V. G., Lima, D. S., Moulaz, I. R., da Silva, B. C., & de Melo, C. B. (2025). Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta‐analysis of randomized clinical trials. International Journal of Dermatology, 64(3), 479-484. https://doi.org/10.1111/ijd.17524
Vancouver
Sobral MVS, Moreira JLML, Rodrigues LK, Rocha P, Pirolla RDC, Soares VG, et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta‐analysis of randomized clinical trials. International Journal of Dermatology. 2025;64(3):479-484. doi:10.1111/ijd.17524
BibTeX
@article{Sobral2025,
author = {Sobral, Milene Vitória Sampaio and Moreira, João Lucas de Magalhães Leal and Rodrigues, Livia Kneipp and Rocha, Paula and Pirolla, Rafaela da Cunha and Soares, Victor Gonçalves and Lima, Davi Santos and Moulaz, Isac Ribeiro and da Silva, Beatrhiz Costa and de Melo, Caroline Baima},
title = {Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta‐analysis of randomized clinical trials},
journal = {International Journal of Dermatology},
year = {2025},
volume = {64},
number = {3},
pages = {479--484},
doi = {10.1111/ijd.17524}
}
EUVIMED